Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study.

Bryostatin 1, a novel antineoplastic agent and protein kinase C (PKC) activator, has been found to induce myalgia (muscle pain) 48 h after administration in clinical trials. This is the dose-limiting toxicity and has restricted the duration of therapy in phase I trials. To investigate the mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickman, P. F., Kemp, G. J., Thompson, C. H., Salisbury, A. J., Wade, K., Harris, A. L., Radda, G. K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034030/
https://www.ncbi.nlm.nih.gov/pubmed/7547256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034030/
https://www.ncbi.nlm.nih.gov/pubmed/7547256

Ejemplares similares